首页> 美国卫生研究院文献>PLoS Clinical Trials >Rutin derivatives obtained by transesterification reactions catalyzed by Novozym 435: Antioxidant properties and absence of toxicity in mammalian cells
【2h】

Rutin derivatives obtained by transesterification reactions catalyzed by Novozym 435: Antioxidant properties and absence of toxicity in mammalian cells

机译:通过Novozym 435催化的酯交换反应获得的芦丁衍生物:哺乳动物细胞中的抗氧化特性和无毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Flavonoids are one of the most important and diversified phenolic groups among products of natural origin. An important property of this metabolite class is the antioxidant action. This study evaluated the antioxidant and cytotoxic activities and oxidative stress of transesterification products of the flavonoid rutin, catalyzed by Novozym® 435. The presence of monoacetate and diacetate was confirmed by quantitative evaluation of the retention times (rutin, 15.68 min; rutin monoacetate, 18.14 min; and rutin diacetate, 18.57 min) and by the data from LC-MS and NMR 1H and 13C. The experiment showed excellent conversion values of 96% in total acetates (rutin monoacetate and diacetate). These results confirmed that rutin derivatives have antioxidant potential, as evaluated by the ORAC method (rutin standard: 0.53 ± 0.08 μM Trolox/g and rutin derivatives: 2.33 ± 1.08 μM Trolox/g) and also show low cytotoxicity in human and animal cells. Rutin derivatives reduced the production of reactive oxygen species in RAW macrophages as well. Many qualities attributed to rutin derivatives make them promising potential candidates for use as nutraceuticals, including their high amounts of antioxidants, biological potential and low toxicity, which contribute to the reduction of oxidative stress.
机译:类黄酮是天然来源产品中最重要和最多样化的酚基之一。这类代谢产物的重要特性是抗氧化作用。这项研究评估了Novozym ® 435催化的类黄酮芦丁酯基转移酯化产物的抗氧化,细胞毒活性和氧化应激。根据LC-MS和NMR 1 H和 13 C的数据,分别需要15.68分钟,单乙酸芦丁18.14分钟和双乙酸芦丁18.57分钟。实验表明,总乙酸盐(芦丁单乙酸盐和二乙酸盐)的转化率极佳,为96%。这些结果证实了芦丁衍生物具有抗氧化能力,如通过ORAC方法评估的那样(芦丁标准:0.53±0.08μMTrolox / g和芦丁衍生物:2.33±1.08μMTrolox / g),并且在人和动物细胞中显示出低细胞毒性。芦丁衍生物也减少了RAW巨噬细胞中活性氧的产生。芦丁衍生物的许多特性使它们成为有前景的潜在的营养保健品候选物,包括其大量的抗氧化剂,生物潜力和低毒性,这些都有助于减少氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号